Lower GDM diagnostic thresholds raise diagnoses without improving short-term outcomes
A systematic review and meta-analysis of 17 studies (nine RCTs, one cohort, 81,528 women) compared lower versus higher glycemic diagnostic criteria for gestational diabetes. The review found lower thresholds doubled GDM diagnosis and pharmacotherapy use and increased neonatal hypoglycemia and maternal-neonatal separation, with little effect on other short-term outcomes; one RCT's five-year follow-up suggested possible reductions in maternal hypertension and child neurodevelopmental impairment but increased subsequent GDM, and cost data were inconsistent with no long-term economic data available.
Most relevant for: Clinicians involved in screening and diagnostic threshold decisions for gestational diabetes during pregnancy.
Read the original at The Journal of Clinical Endocrinology & MetabolismSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More endocrinology updates
- Experts debate TSH threshold for levothyroxine use in pregnancyOct 27, 2026
- Review reappraises menopausal hormone therapy safety, emphasizes timing and formulationOct 23, 2026
- 2025 ATA thyroglobulin cutoff may miss recurrences in higher-risk DTCOct 13, 2026
- ADA-EASD 2026 consensus favors earlier SGLT2/GLP-1 use in type 2 diabetesOct 2, 2026
- Lean MASLD shows milder liver histology but similar clinical outcomesSep 30, 2026